Dr. Agarwal's Health Care Limited

BSE: AGARWALEYE544350ISIN INE943P01029

Healthcare
Hospital
BSE 1000

Share price

₹524.15+11.60 (+2.26%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹567.30
52W low: ₹402.10
Off 52W high: -7.61%
1M return: +8.33%
3M return: +0.24%
6M return: +14.41%
1Y return: +1.80%
20D avg volume: 13,327
50 DMA: ₹493.87
200 DMA: ₹470.34

Key ratios Consolidated

Market cap: ₹16,618 Cr
Current price: ₹524.15
52W high / low: ₹567.30 / ₹402.10
Face value: ₹1.00
P/E: 89.77
P/B: 8.20
EPS (TTM): ₹5.84
Book value / share: ₹63.94
ROE: —
ROCE: 9.70%
Operating margin: —
Net margin: —
Debt / equity: 0.07
Net debt: ₹66.72 Cr
Interest cover: 3.75
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 18.5 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q4 FY24
Income statement
	614.02	564.11	529.86	498.69	487.42	460.22	430.72	—
	6.41	12.58	10.54	7.93	13.39	15.43	12.71	—
	620.43	576.69	540.40	506.62	500.81	475.65	443.43	—
	545.29	501.40	475.64	452.96	447.21	414.63	402.44	—
	0.32	0.24	0.22	0.19	0.21	0.29	0.39	—
	64.52	57.79	50.33	45.07	49.21	44.18	40.68	—
	121.04	103.79	105.36	99.12	95.52	87.14	83.87	—
	23.37	22.08	21.13	22.55	24.70	25.01	28.35	—
	78.31	76.68	68.75	67.86	62.95	60.39	58.18	—
	263.40	246.57	233.73	217.23	216.40	198.24	73.51	—
	75.14	75.29	64.76	53.66	53.60	61.02	40.99	—
	0.00	1.33	0.00	0.00	0.00	-2.50	0.00	—
	75.14	76.62	64.76	53.66	53.60	58.52	40.99	—
	20.12	26.66	21.13	17.17	15.54	15.97	12.75	—
	55.02	49.96	43.63	36.49	38.06	42.55	28.24	—
	1.43	1.25	1.07	0.94	0.95	1.04	0.73	—
Key metrics
	176.82	175.38	154.64	144.07	141.25	143.92	127.52	—
	28.80%	31.10%	29.20%	28.90%	29.00%	31.30%	29.60%	—
	9.00%	8.90%	8.20%	7.30%	7.80%	9.20%	6.60%	—
	—	2.80%	—	2.30%	—	2.60%	—	—
	26.00%	22.60%	23.00%	—	—	—	—	—
	44.60%	17.40%	54.50%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	2,207	2,080	1,711	—
	37.46	44.44	46.02	—
	2,244	2,125	1,757	—
	1,975	1,877	1,594	—
	0.97	0.86	1.18	—
	217.71	202.38	173.73	—
	429.31	403.79	326.87	—
	89.13	90.46	108.79	—
	291.60	276.24	230.74	—
	960.93	913.93	765.65	—
	268.85	247.31	162.87	—
	1.33	1.33	-3.02	—
	270.18	248.64	159.85	—
	85.08	80.50	49.51	—
	185.10	168.14	110.34	—
	4.69	4.21	2.80	—
Key metrics
	650.91	615.34	499.38	—
	29.50%	29.60%	29.20%	—
	8.39%	8.10%	6.40%	—
	—	9.70%	8.40%	—
	—	21.60%	—	—
	—	52.40%	—	—
	—	71.04	51.69	—
	—	3.09	3.27	—
	—	0.07	0.13	—
	—	66.72	143.26	—
	—	18.5	10.9	—
Balance sheet
	—	3,942	3,672	—
	—	572.97	794.07	—
	—	90.55	103.61	—
	—	160.91	123.56	—
	—	94.03	80.27	—
	—	23.05	18.53	—
	—	926.49	707.68	—
	—	149.26	153.05	—
	—	461.48	477.76	—
	—	157.27	246.87	—
	—	23.97	89.58	—
	—	133.30	157.29	—
	—	2,120	1,927	—
Cash flow
	—	518.99	360.33	—
	—	-308.45	-750.31	—
	—	-220.39	381.85	—
	—	447.95	308.64	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q4 FY24
Income statement
	382.62	347.86	334.84	308.98	301.72	281.02	267.93	—
	3.42	6.21	7.11	6.81	13.03	26.93	10.48	—
	386.04	354.07	341.95	315.79	314.75	307.95	278.41	—
	363.54	330.75	320.84	305.51	298.45	270.69	265.60	—
	0.00	0.00	0.00	0.00	0.00	0.00	—	—
	41.25	35.39	31.13	27.20	27.73	28.48	29.09	—
	71.07	61.11	62.85	58.86	55.19	50.57	47.21	—
	18.96	18.66	17.77	17.29	19.32	20.90	23.38	—
	57.53	56.10	48.27	48.10	44.21	42.20	39.00	—
	180.80	163.32	162.85	154.47	151.43	130.76	47.79	—
	22.50	23.32	21.11	10.28	16.30	37.26	12.81	—
	0.00	-4.91	-0.71	-0.72	-0.71	-3.21	-0.71	—
	22.50	18.41	20.40	9.56	15.59	34.05	12.10	—
	5.83	7.81	6.34	4.88	5.48	7.54	4.48	—
	16.67	10.60	14.06	4.68	10.11	26.51	7.62	—
	0.53	0.33	0.44	0.15	0.32	0.85	0.25	—
Key metrics
	98.99	93.17	86.44	74.95	79.12	97.15	74.48	—
	25.90%	26.80%	25.80%	24.30%	26.20%	34.60%	27.80%	—
	4.40%	3.00%	4.20%	1.50%	3.40%	9.40%	2.80%	—
	—	1.40%	—	1.00%	—	2.20%	—	—
	26.80%	23.80%	25.00%	—	—	—	—	—
	64.90%	-60.00%	84.50%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	1,374	1,293	1,044	—
	23.55	33.16	53.81	—
	1,398	1,327	1,098	—
	1,321	1,256	1,045	—
	0.00	0.00	0.00	—
	134.97	121.30	108.14	—
	253.89	238.01	186.34	—
	72.68	73.04	90.30	—
	210.00	196.68	156.01	—
	661.44	632.07	514.68	—
	77.21	71.01	52.60	—
	-6.34	-7.05	-14.00	—
	70.87	63.96	38.60	—
	24.86	24.51	16.67	—
	46.01	39.45	21.93	—
	1.45	1.25	0.74	—
Key metrics
	353.55	333.68	284.91	—
	25.73%	25.80%	27.30%	—
	3.35%	3.10%	2.10%	—
	—	5.20%	5.20%	—
	—	23.90%	—	—
	—	79.90%	—	—
	—	10.88	25.15	—
	—	8.13	9.48	—
	—	0.04	0.08	—
	—	36.43	89.40	—
	—	10.7	6.5	—
Balance sheet
	—	2,961	2,837	—
	—	306.95	630.91	—
	—	34.78	55.82	—
	—	83.10	72.59	—
	—	53.72	46.68	—
	—	9.69	10.68	—
	—	672.13	475.03	—
	—	99.37	100.54	—
	—	308.69	341.84	—
	—	71.21	145.22	—
	—	8.51	73.68	—
	—	62.70	71.54	—
	—	1,991	1,934	—
Cash flow
	—	320.72	208.00	—
	—	-166.86	-577.46	—
	—	-172.61	374.08	—
	—	309.84	182.85	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 32.33%

Holder	Type	Holding	Previous	Change
HYPERION INVESTMENTS PTE. LTD.	Public	15.47%	—	—
ARVON INVESTMENTS PTE.LTD.	Public	9.87%	—	—
GOVERNMENT OF SINGAPORE	Public	6.16%	—	—
INVESCO INDIA FLEXI CAP FUND	Public	5.52%	—	—
CLAYMORE INVESTMENTS (MAURITIUS) PTE. LTD	Public	5.17%	—	—
ICICI PRUDENTIAL HEALTHCARE FUND	Public	5.06%	—	—
ATHIYA AGARWAL	Promoter	4.45%	—	—
ASHVIN AGARWAL	Promoter	4.45%	—	—
AMAR AGARWAL	Promoter	4.45%	—	—
ASHAR AGARWAL	Promoter	4.45%	—	—
ADIL AGARWAL	Promoter	4.43%	—	—
ADIL AGARWAL, ANOSH AGARWAL, ASHVIN AGARWAL	Promoter	4.27%	—	—
ANOSH AGARWAL	Promoter	4.23%	—	—
POLAR CAPITAL FUNDS PLC - HEALTHCARE OPPORTUNITIES	Public	2.76%	—	—
MOTILAL OSWAL S&P BSE HEALTHCARE ETF	Public	1.59%	—	—

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Apollo Hospitals Enterprises Ltd.	1,23,324	8,577.00	56.78	19.50%	+19.24% TTM	+35.20% TTM	+9.78%
Max Healthcare Institute Limited	90,129	926.00	65.28	12.70%	+15.17% TTM	+1.73% TTM	-18.59%
Manipal Health Enterprises Limited	87,828	667.70	—	—	—	—	—
ASTER DM QUALITY CARE LIMITED	62,665	718.90	172.72	10.20%	+15.70% TTM	+3.89% TTM	+4.39%
Fortis Healthcare Ltd	59,710	790.90	55.79	12.00%	+17.50% TTM	+18.62% TTM	-22.35%
Narayana Hrudayalaya Limited	39,427	1,929.30	45.89	11.40%	+71.40% TTM	+1.61% TTM	+5.41%
Global Health Limited	37,682	1,401.45	61.46	15.00%	+26.18% TTM	+9.16% TTM	+12.21%
Krishna Institute of Medical Sciences Limited	31,074	739.85	159.85	8.20%	+30.90% TTM	-51.92% TTM	+3.15%
Dr. Agarwal's Health Care Limited	16,618	524.15	89.77	9.70%	—	—	+1.80%
Rainbow Children's Medicare Limited	12,990	1,278.95	43.51	16.80%	+22.83% TTM	+17.12% TTM	-8.02%
PARK MEDI WORLD LIMITED	9,958	230.55	—	18.10%	—	—	—
YATHARTH HOSPITAL & TRAUMA CARE SERVICES LIMITED	9,900	1,027.45	54.50	11.00%	+50.40% TTM	+19.12% TTM	+25.09%
HealthCare Global Enterprises Limited	9,286	621.95	279.19	6.90%	+13.77% TTM	-19.23% TTM	—
Jupiter Life Line Hospitals Limited	9,178	279.95	49.57	13.80%	+16.71% TTM	-6.85% TTM	-9.74%
Paras Healthcare Limited	8,135	751.85	—	—	—	—	—
Kovai Medical Center & Hospital Ltd S	6,561	5,996.35	25.97	20.60%	+14.96% TTM	+16.29% TTM	-1.95%
Artemis Medicare Services Limited	4,758	300.60	41.36	13.70%	+14.77% TTM	+21.46% TTM	+22.59%
Indraprastha Medical Corporation Lt S	3,092	337.25	16.09	30.70%	+10.72% TTM	+9.95% TTM	-44.21%
Dr.Agarwals Eye Hospital Ltd. S	2,616	5,413.80	34.33	16.10%	+20.01% TTM	+31.87% TTM	+2.39%
KMC Speciality Hospitals India Limited S	2,453	150.40	43.98	24.60%	+35.05% TTM	+137.83% TTM	+118.35%
Shalby Limited	1,336	123.70	35.06	7.90%	+7.27% TTM	+17,422.73% TTM	-49.15%
GUJARAT KIDNEY AND SUPER SPECIALITY LIMITED	1,260	159.75	75.29	8.60%	—	—	—
GPT Healthcare Limited S	1,152	140.45	24.38	16.40%	+18.07% TTM	-0.78% TTM	-5.48%
Rays of Belief Limited	528	252.45	—	—	—	—	—
ASARFI HOSPITAL LIMITED	347	176.40	—	18.40%	—	—	+22.97%

Some figures use IPO-document inputs. Growth periods are shown per value; FY means annual.

Filings & corporate actions

Recent announcements

Intimation of Analyst / Earnings Conference call to discuss the Unaudited Financial Results (Standalone & Consolidated) of the Company for the Quarter and Half-Year ended September 30, ....23 Oct 2026 · Company Update / Analyst / Investor Meet
Dr. Agarwals Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve the Unaudited Financial ....23 Oct 2026 · Board Meeting / Board Meeting
Allotment of 18,200 Equity Shares pursuant to the exercise of options granted under Dr. Agarwal''s Health Care Limited - Employees Stock Option Scheme 202220 Oct 2026 · Company Update / Allotment of ESOP / ESPS
Fixation of Record Date w.r.t. the Scheme of Amalgamation between Dr. Agarwals Eye Hospital Limited and Dr. Agarwals Health Care Limited, is disclosed.20 Oct 2026 · Corp. Action / Record Date
Outcome of Board Meeting held on October 20, 2026 in connection with a Material Update on Scheme of Amalgamation between Dr. Agarwal''s Eye Hospital Limited and Dr. Agarwal''s Health Care ....20 Oct 2026 · Others / Outcome without intimation
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026, is enclosed.7 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Receipt of sanction from the Honble NCLT, Chennai Bench towards the scheme of amalgamation between Dr. Agarwals Eye Hospital Limited and Dr. Agarwals Health Care Limited and their respective ....5 Oct 2026 · Company Update / Scheme of Arrangement
Update on Step-down wholly owned subsidiary in Nigeria by Orbit Healthcare Services (Mauritius) Limited, a direct wholly owned subsidiary of the Company.29 Sep 2026 · Company Update / Acquisition
Completion of Second Term of 5 (Five) Consecutive Years by Mr. Sanjay Anand (DIN: 02501139), Independent Director of the Company29 Sep 2026 · Company Update / Cessation
Closure of Trading Window pursuant to Dr. Agarwals Health Care Limited - Code of Conduct for Prevention of Insider Trading28 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Voting Results and the Consolidated Scrutinizer''s Report of the 16th AGM of the Company, is submitted.21 Sep 2026 · AGM/EGM / AGM
Proceedings of the 16th Annual General Meeting of Dr. Agarwal''s Health Care Limited held on Monday, September 21, 2026, is submitted.21 Sep 2026 · AGM/EGM / AGM
Newspaper Advertisement - Sixteenth Annual General Meeting of Dr. Agarwals Health Care Limited, Instructions for e-Voting and Other Related Information, is submitted.29 Aug 2026 · Company Update / Newspaper Publication
Annual Report of the Company for the Financial Year 2025-26, is submitted.28 Aug 2026 · Others / Reg. 34 (1) Annual Report
Notice convening the Sixteenth AGM of the Company on September 21, 2026, along with the Annual Report for the financial year 2025-26, is submitted.28 Aug 2026 · AGM/EGM / AGM
Media Release - Launch of World''s First Pinhole Pupilloplasty (PPP) Centre by Dr. Agarwals Eye Hospital Limited, a subsidiary of the Company, is submitted27 Aug 2026 · Company Update / Press Release / Media Release
Intimation of Schedule of Analyst / Investors Meet is submitted.25 Aug 2026 · Company Update / Analyst / Investor Meet
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd25 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for DB International Trust (Singapore) Ltd14 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Claymore Investments (Mauritius) Pte Ltd14 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hyperion Investments Pte Ltd14 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Invesco Mutual Fund14 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd14 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for ICICI Prudential Mutual Fund14 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Transcript of the discussion held on the Unaudited Financial Results (Consolidated & Standalone) of the Company for the quarter ended June 30, 2026, at the analyst call held on August 04, ....7 Aug 2026 · Company Update / Earnings Call Transcript
Link for the Audio recording of the Analyst / Earnings Conference call held on the Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter ended June 30, ....4 Aug 2026 · Company Update / Analyst / Investor Meet
Dr. Agarwal''s Health Care Limited - Monitoring Agency Report for the quarter ended June 30, 2026, is submitted.4 Aug 2026 · Company Update / Monitoring Agency Report
Presentation on the Unaudited Financial Results (Consolidated & Standalone) of the Company for the quarter ended June 30, 2026, is attached.4 Aug 2026 · Company Update / Investor Presentation
Consolidated and Standalone Unaudited Financial Results of the Company for the quarter ended June 30, 2026 is submitted.4 Aug 2026 · Result / Financial Results
Outcome of the Meeting of the Board of Directors of the Company held on August 04, 2026, is attached.4 Aug 2026 · Board Meeting / Outcome of Board Meeting
Intimation of Analyst / Earnings Conference call to discuss the Unaudited Financial Results (Standalone & Consolidated) of the Company For The Quarter Ended June 30, 2026, is attached28 Jul 2026 · Company Update / Analyst / Investor Meet
Dr. Agarwals Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 ,inter alia, to consider and approve the Unaudited Financial ....28 Jul 2026 · Board Meeting / Board Meeting
Newspaper Advertisement of Notice of Hearing of the Company''s Petition in relation to the Scheme of Amalgamation between Dr. Agarwal''s Eye Hospital Limited and Dr. Agarwal''s Health Care ....20 Jul 2026 · Company Update / Newspaper Publication
Allotment of 43,155 Equity Shares pursuant to the exercise of options granted under Dr. Agarwal''s Health Care Limited - Employee Stock Option Scheme 2022.9 Jul 2026 · Company Update / Allotment of ESOP / ESPS
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026 is enclosed.7 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Voting Results and the Consolidated Scrutinizer''s Report on the Hon''ble NCLT convened meeting of the unsecured creditors of Dr. Agarwal''s Health Care Limited held on July 02, 2026, is enclosed.2 Jul 2026 · Company Update / General
Summary of the Proceedings of the Hon''ble NCLT convened meeting of the Unsecured Creditors of Dr. Agarwal''s Health Care Limited held on July 02, 2026, is enclosed.2 Jul 2026 · Company Update / General
Voting Results and the Consolidated Scrutinizer''s Report on the Hon''ble NCLT convened meeting of the Equity Shareholders of Dr. Agarwal''s Health Care Limited held on July 02, 2026, is enclosed.2 Jul 2026 · Company Update / General
Summary of the Proceedings of the Hon''ble NCLT convened meeting of the Secured Creditors of Dr. Agarwal''s Health Care Limited held on July 02, 2026, is enclosed.2 Jul 2026 · Company Update / General
Voting Results and the Consolidated Scrutinizer''s Report on the Hon''ble NCLT convened meeting of the Equity Shareholders of Dr. Agarwal''s Health Care Limited held on July 02, 20262 Jul 2026 · AGM/EGM / Court Convened Meeting

Board meetings

5 Nov 2026 Board Meeting - Financial Results
4 Aug 2026 Board Meeting - Financial Results